Sign in to view your email alerts and activity

Sign in

To view your email alerts and activity.
We will send you an email to confirm your email address.

Do you Suffer from Recurring UTIs?

Alfred Health
Logo for Alfred Health

Have you experienced at least 3 urinary tract infections (UTIs) in a year, or 2 infections in 6 months? If so, we invite you to participate in this study! About 250,000 Australians will develop a UTI at some point during their lifetime. UTIs are common and it is estimated that around 11% of women over the age of 18 will experience at least one UTI within a year. Prevention of recurrent UTIs are typically managed with either long term antibiotic use or antibiotics used following sexual activity. Ongoing antibiotic treatment can be associated with a number of possible side effects such as bacterial resistance and increased financial cost. The consumption of cranberries has long been investigated as a potential therapeutic intervention for the prevention of recurrent UTI. This study aims to investigate the effectiveness of high strength cranberry supplementation for its potential to reduce UTI reoccurrence in women with a history of recurrent UTIs, over a 6-month intervention period. This will assist health care professionals with recommendations to their patients and provide consumers with a natural strategy to prevent recurrent UTIs, without the need to rely on antibiotics.

  • Women aged 18 to 65 years who experience recurrent urinary tract infections may be eligible to participate in this study.
  • If you are suitable for the study, you will undergo a screen onsite at MAPrc.
  • The study consists of 4 clinic visits to our Melbourne Centre (in months 1, 3, & 6 of the trial) + 5 short online questionnaires (in months 2, 4, 5 & 6 of the trial).

For the duration of the 6 month intervention period, we will provide you with a supply of soft gel capsule supplements. You will be randomly assigned to receive either the high strength cranberry or placebo (a control supplement that looks identical to the treatment but contains no active ingredients that are being tested).

A diagnosis of diabetes, or any gastrointestinal, kidney, or liver diseases would exclude you from participating in this trial. Eligibility is also subject to a screening visit. 

You can not apply for this role as it is no longer available.